XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency 
Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors
NEW YORK and SALT LAKE CITY, March 30, 2022 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced...
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
Galderma launched TWYNEO® at the Annual Meetings of the American Academy of Dermatology, March 25-29, 2022 in Boston, MA. TWYNEO...
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform
– Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase...
Design Therapeutics Completes Dosing in First Patient Cohort of Phase 1 Trial of DT-216 GeneTAC™ Molecule for the Treatment of Friedreich Ataxia
Topline Data from Phase 1 Trial Expected in the Second Half of 2022 DT-216 Granted FDA Fast Track Designation for...
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Fourth quarter and full year revenues of €5.5 billion1 and €19.0 billion1, respectivelyFull year net income of €10.3 billion and...
Neuronascent Releases Further Positive Results of NNI-362 in A Randomized Phase 1a Trial for Alzheimer’s Disease
ROCKVILLE, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., is a clinical-stage pharmaceutical company discovering and developing novel regenerative...
Ultimovacs to host Investor Days 2022: Meet the Team
Oslo, 30 March 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, will...
Aino Health AB (publ): Aino expands agreement with DHL Supply Chain to include all employees in Sweden
Stockholm, Sweden, March 30: DHL Supply Chain Sweden AB chooses to extend the agreement with Aino Health to the remaining...
Calithera Biosciences, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock and Warrants to Purchase Common Stock
SOUTH SAN FRANCISCO, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical...
Press Release: Availability of the Q1 2022 Memorandum for modelling purposes
Availability of the Q1 2022 Memorandum for modelling purposes Paris, March 30, 2022. Sanofi announced today that its Q1 2022...
Lobe Sciences Ltd. to Participate in the Lytham Partners Spring 2022 Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company")...
Psyched Wellness Unveils New Product Name and Visual Identity Elements
Toronto, Ontario--(Newsfile Corp. - March 30, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Metabolic Health Company Lumen Launches Partnership Providing Chef-made Meals Based on Your Metabolism
The future of personalized nutrition based on your metabolism has arrived at your door. NEW YORK--(BUSINESS WIRE)--#lumenmetabolism--Lumen, a health technology...
Daniel Johnson Joins TailorMed as a Board Director
CEO, entrepreneur and healthcare visionary Daniel Johnson to help accelerate growth and expand market leadership for VC-funded digital financial health...
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
• Phase 1 dose-escalation study started at clinical sites in the U.S. • Milestone demonstrates CureVac’s and GSK’s continued execution...
Kareo Cloud Empowers Data-Driven Decision Making for Financial and Operational Success
Large Billing Company in Maryland Is Using Kareo Cloud to Uncover Actionable Insights to Enhance Financial Performance IRVINE, Calif.--(BUSINESS WIRE)--#Kareo--Kareo,...
Is microplastic carcinogenic?
The effects of micro- and nanoplastic particles (MNP) in the human body are being investigated in depth for the first...
HepaRegeniX Appoints Elias Papatheodorou as New Chairman of the Board of Directors
TUBINGEN, GERMANY / ACCESSWIRE / March 30, 2022 / HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapy approaches...
indie Semiconductor Announces Retirement of Bill Woodward and Appointment of Diane Biagianti to Its Board of Directors
Original indie Investor and Partner Steps Down post IPO while Adding Legal Executive who Brings Broad Corporate Governance Experience ALISO...
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Conference call to be held today at 4:30 PM EDT NEW YORK--(BUSINESS WIRE)--$PAVM #earnings--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”...